COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCER TREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING

被引：0
|
作者：
Kawalec, P. [1 ]
Szawlowski, A. [2 ,3 ]
Federowicz, I [2 ,3 ]
Szkultecka-Debek, M. [4 ]
Russel-Szymczyk, M. [4 ]
机构：
[1] Centrum HTA, Krakow, Poland
[2] M Sklodowska Curie Mem Canc Ctr, Warsaw, Poland
[3] Inst Oncol, Warsaw, Poland
[4] Roche Polska, Warsaw, Poland
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66580-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A473 / A473
页数：1
相关论文
共 50 条
  • [41] Predictive value of genomic polymorphisms on clinical outcome to cisplatin/5-FU chemotherapy in patients with advanced gastric cancer
    Goekkurt, Eray
    Wittmer, Corinna
    Wolschke, Christine
    Stueber, Christian
    Hoehn, Stephan
    Laack, Eckart
    Erbersdobler, Andreas
    Hossfeld, Dieter K.
    Stoehlmacher, Jan
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 237 - 238
  • [42] The clinical studies of weekly Taxol plus Cisplatin and continuous infusion of 5-FU in patients with advanced gastric cancer
    Jia, Chen
    Ling, Hang F.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 234 - 234
  • [43] A Single Institution Analysis of Neoadjuvant Chemoradiation using Cisplatin with 5-FU or Irinotecan in the Treatment of Locally Advanced Esophageal Cancer
    Christensen, Michael
    Cannon, George
    Weigel, Tracey
    Holen, Kyle
    Mulkerin, Daniel
    LoConte, Noelle
    Ritter, Mark
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (06): : 616 - 616
  • [44] EFFICACY OF CAPECITABINE VS. 5-FU IN COLORECTAL AND GASTRIC CANCER: UPDATED META-ANALYSIS OF SURVIVAL IN 6 CLINICAL TRIALS
    Cassidy, J.
    Saltz, L.
    Twelves, C.
    Van Cutsem, E.
    Hoff, P.
    Kang, Y.
    Saini, J.
    Gilberg, F.
    Cunningham, D.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 79 - 79
  • [45] Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer
    Pera, M.
    Gallego, R.
    Montagut, C.
    Martin-Richard, M.
    Iglesias, M.
    Conill, C.
    Reig, A.
    Balague, C.
    Petriz, L.
    Momblan, D.
    Bellmunt, J.
    Maurel, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (03) : 664 - +
  • [46] Adjuvant 5-FU/cisplatin (FP) chemotherapy in curatively resected stage IIIA-IV MO gastric cancer.
    Kim, TM
    Kim, JS
    Im, SA
    Kim, TY
    Yang, HK
    Kim, WH
    Heo, DS
    Bang, YJ
    Lee, KU
    Kim, NK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 361S - 361S
  • [47] Cost-minimization analysis of capecitabine plus oxaliplatin (XELOX) vs. infusional 5-FU/LV + oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer (MCRC) in the French setting
    Perrocheau, G.
    Ducreux, M.
    Hebbar, M.
    Ychou, M.
    Lledo, G.
    Conroy, T.
    Faroux, R.
    Douillard, J. Y.
    Pacull, A.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A233 - A233
  • [48] In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: Timing of cisplatin treatment
    Cho H.
    Imada T.
    Oshima T.
    Shiozawa M.
    Rino Y.
    Takanashi Y.
    [J]. Gastric Cancer, 2002, 5 (1) : 43 - 46
  • [49] Untreated metastatic diffuse gastric adenocarcinoma (DGAC): Randomized phase III study of S-1 and cisplatin vs. 5-FU and cisplatin (the DIGEST trial)
    Ajani, Jaffer A.
    Abramov, Mikhail
    Bondar, Volodymyr
    Bondarenko, Igor
    Shparyk, Yaroslav V.
    Gorbunova, Vera
    Anatoliy, Hontsa
    Vinnyk, Yuriy
    Alsina, Maria
    Lazarev, Sergey
    Feliu, Jaime
    Elme, Anneli
    Esko, Vivian
    Rosati, Gerardo
    Abdalla, Kathia Cristina
    Verma, Udit N.
    Benedetti, Fabio M.
    Aoyama, Takekazu
    Mizuguchi, Hirokazu
    Makris, Lukas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study
    Katja Ott
    Andreas Sendler
    Karen Becker
    Hans-Joachim Dittler
    Hermann Helmberger
    Raimonde Busch
    Christian Kollmannsberger
    J. Rüdiger Siewert
    Ulrich Fink
    [J]. Gastric Cancer, 2003, 6 (3) : 159 - 167
12345